RxDoctor Payments Data

Noah Stern, DO

Facial Plastic Surgery · Detroit, MINPI 1972727576

Payments from drug & device makers

What this record shows

12 manufacturers reported payments, led by Metrex Research, LLC at 44.6% of the total. Reporting peaked in 2021 at $2,185 and has fallen 80.6% since, to $424 in 2025.

$4,021in general payments, 2019–2025

Across 24 payments — averaging $167.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Metrex Research, LLC$2K
  • Stryker$555
  • Acclarent, Inc$393
  • Zimmer Biomet$335
  • Intersect ENT, Inc.$265
  • Kerecis Limited$170
  • plus $507 from 6 others

What the payments were for

  • Food & beverage$2,22655%
  • Education$1,79545%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,021 in reported general payments places this provider in the 75th percentile of 30 facial plastic surgery providers in Michigan.

See all facial plastic surgery providers in Michigan

Medicare billing

Part B allowed, 2024
$101,651
Medicare patients
370
Services billed
987

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip107$4,565
Azelastine Hcl147$3,714
Fluticasone Propionate209$2,729
Ipratropium Bromide42$1,269
Fluocinolone Acetonide Oil17$796
Omeprazole43$750
Famotidine23$312
Clindamycin Hcl13$191
Montelukast Sodium20$112
Mupirocin14$96
Prednisone11$26

Paid to pharmacies, not to this prescriber.

Other facial plastic surgery in Detroit

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →